A racemic mixture of dexrazoxane and levrazoxane
Related Products
Isomer(s)
14632Dexrazoxane
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Razoxane

Item No. 45123

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
4,4′-(1-methyl-1,2-ethanediyl)bis-2,6-piperazinedione
CAS Number
21416-67-1
Synonyms
  • ICI 59118
  • ICRF 159
  • NSC 129943
Molecular Formula
C11H16N4O4
Formula Weight
268.3
Purity
≥95%
Formulation
A solid
Solubility(Learn about Variance in Solubility)
DMSO: Soluble: ≥ 10 mg/ml
SMILES
O=C1NC(CN(CC(C)N2CC(NC(C2)=O)=O)C1)=O
InChi Code
InChI=1S/C11H16N4O4/c1-7(15-5-10(18)13-11(19)6-15)2-14-3-8(16)12-9(17)4-14/h7H,2-6H2,1H3,(H,12,16,17)(H,13,18,19)
InChi Key
BMKDZUISNHGIBY-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    5 mg

    $63

    Add

    10 mg

    $120

    Add

    25 mg

    $252

    Add

    50 mg

    $410

    Add
    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Razoxane is a racemic mixture of dexrazoxane (Item No. 14632) and levrazoxane.1 Unlike dexrazoxane, razoxane inhibits topoisomerase II-α (TOP2A) and TOP2B only weakly (IC50s = 301 and 505 µM, respectively). Razoxane slows tumor growth, normalizes intratumoral vasculature, and prevents metastases in murine Lewis lung carcinoma models when administered at a dose of 30 mg/kg.2,3,4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Jirkovská, A., Karabanovich, G., Kubeš, J., et al. Structure-activity relationship study of dexrazoxane analogues reveals ICRF-193 as the most potent bisdioxopiperazine against anthracycline toxicity to cardiomyocytes due to its strong topoisomerase IIβ interactions. J. Med. Chem. 64(7), 3997-4019 (2021).

    2. Le Serve, A.W., and Hellmann, K. Metastases and the normalization of tumour blood vessels by ICRF 159: A new type of drug action. Br. Med. J. 1(5800), 597-601 (1972).

    3. Salsbury, A.J., Burrage, K., and Hellmann, K. Histological analysis of the antimetastatic effect of (±)-1,2-bis(3,5-dioxopiperazin-1-yl)propane. Cancer Res. 34(4), 843-849 (1974).

    4. Hellmann, K. Dynamics of tumour angiogenesis: Effect of razoxane-induced growth rate slowdown. Clin. Exp. Metastasis 20(2), 95-102 (2003).